Genetics of drug resistance in tuberculosis

Clinics in Chest Medicine

Volumn 18, Issue 1, 1997, Pages 55-64

  Telenti, A ^a  

^a Institute for Medical Microbiology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL GENETICS; BACTERIAL VIRULENCE; DRUG MECHANISM; GENE MUTATION; GENOTYPE; MULTIDRUG RESISTANCE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS;

EID: 0030899870     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70355-5     Document Type: Article

References (58)

1. Banerjee A. Dubnau E. Quemard A. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263 1994 227 230 00a. 1
2. T. Bodmer G. Zu¨rcher I. Imboden Molecular basis of rifabutin susceptibility in rifampicin-resistant M. tuberculosis J Antimicrob Chemother 35 1995 345 348
3. A.E. Belanger G.S. Besra M.E. Ford K. Mikusova J.T. Belisle P.J. Brennan J.M. Inamine The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol Proc Natl Acad Sci USA 21 1996 1919 1924
4. W.R. Butler J.O. Kilburn Susceptibility of Mycobacterium tuberculosis to pyrazinamide and its relationship to pyrazinamidase activity Antimicrob Agents Chemother 24 1983 600 601
5. Caceres N. Barletta R. The molecular basis of resistance to cycloserine 1995 submitted
6. E. Cambau V. Jarlier Resistance to quinolones in mycobacteria Res Microbiol 147 1996 52 59
7. E. Cambau W. Sougakoff M. Basson Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin J Infect Dis 170 1994 479 483
8. G. Canetti The J. Burns Amberson lecture. Present aspects of bacterial resistance in tuberculosis Am Rev Respir Dis 92 1965 687
9. S.T. Cole Mycobacterium tuberculosis: Drug resistance mechanisms Trends Microbiol 2 1994 411 415
10. S.T. Cole Rifamycin resistance in mycobacteria Res Microbiol 147 1996 48 52
11. E.R. Dabbs K. Yazawa Y. Mikami Ribosylation by mycobacterial strains as a new mechanism of rifampin inactivation Antimicrob Agents Chemother 39 1995 1007 1009
12. H. De Beenhouwer Z. Lhiang G. Jannes Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay Tubercle Lung Dis 76 1995 425 430
13. M.B. Delgado A. Telenti Detection of mutations associated with quinolone resistance in Mycobacterium tuberculosis D.H. Persing Selected PCR protocols for emerging infectious diseases 1996 American Society for Microbiology Washington, DC
14. V. Deretic W. Philipp S. Dhandayuthapani Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: Implications for sensitivity to isoniazid Mol Microbiol 17 1995 889 900
15. A. Dessen A. Quemard J.S. Blanchard Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science 267 1995 1638 1641
16. L. Ferrero B. Cameron J. Crouzet Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother 39 1995 1554 1558
17. M. Finken P. Kirschner A. Meier Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: Alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot Mol Microbiol 9 1993 1239 1246
18. C. Guerrero L. Stockman T. Bodmer Evaluation of the rpoB in rifampin-susceptible and resistant Mycobacterium avium and M. intracellulare. J Antimicrob Chemother 33 1994 661 663
19. I. Guillemin E. Cambau V. Jarlier Sequences of a conserved region in the A subunit of DNA gyrase from nine species of the genus Mycobacterium: Phylogenetic analysis and implications for intrinsic susceptibility to quinolones Antimicrob Agents Chemother 39 1995 2145 2149
20. L.B. Heifets P.J. Lindholm M.D. Iseman Rifabutin: Minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis. Am Rev Respir Dis 137 1988 719 721
21. B. Heym P.M. Alzari N. Honore´ Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. Mol Microbiol 15 1995 235 245
22. B. Heym N. Honore´ C. Truffot-Pernot Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: A molecular study Lancet 344 1994 293 298
23. N. Honore´ S.T. Cole Streptomycin resistance in mycobacteria Antimicrob Agents Chemother 38 1994 238 242
24. Honore´ N. Telenti A. Ortega A. Large-scale evaluation of PCR-SSCP for the identification of multidrug-resistant tuberculosis 1996 submitted
25. Telenti A. Honoré B. Bernasconi C. March J. Ortega A. Takiff H. Cole S.T. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis : a blind study at reference laboratory level J Clin Microbiol March 1997 in press
26. V. Jarlier H. Nikaido Permeability barrier to hydrophilic solutes in Mycobacterium chelonei. J Bacteriol 172 1990 1418 1423
27. V. Kapur L. Ling-Ling M.R. Hamrick Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing Arch Pathol Lab Med 119 1995 138 130
28. H.H. Kwon H. Tomioka H. Saito Distribution and characterization of β-lactamases of mycobacteria and related organisms Tubercle Lung Dis 76 1995 141 148
29. E.M. Lincoln Epidemics of tuberculosis Adv Tuberc Res 14 1965 157 201
30. J.A. Maddry W.J. Suling R.C. Reynolds Glycosyl transferases as targets for inhibition of cell wall synthesis in M. tuberculosis and M. avium. Res Microbiol 147 1996 106 112
31. C. Martin M. Ranes B. Gicquel Plasmids, antibiotic resistance, and mobile elements in mycobacteria J. McFadden Molecular biology of the mycobacteria 1990 Surrey University Press Guildford 121 138
32. A. Meier P. Kirschner B. Springer Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob Agents Chemother 38 1994 381 384
33. K. Mikusova R.A. Slayden G.S. Besra Biogenesis of the mycobacterial cell wall and the site of action of ethambutol Antimicrob Agents Chemother 39 1995 2484 2489
34. D. Mitchison Drug resistance in mycobacteria Br Med Bull 40 1985 84 90
35. S. Morris G. Han Bai P. Suffys Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J Infect Dis 171 1995 954 960
36. S.L. Morris D.A. Rouse The genetics of multiple drug resistance in M. tuberculosis and the M. avium complex Res Microbiol 147 1996 68 73
37. H. Nikaido Prevention of drug access to bacterial targets: Permeability barriers and active efflux Science 264 1994 382 388
38. D.J. Ordway M.G. Sonnenberg S.A. Donahue Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice Infect Immun 63 1995 741 743
39. R. Reves D. Blakey D.E. Snider Jr Farer L.S. Transmission of multiple drug resistance tuberculosis: a report of a school and community outbreak Am J Epidemiol 113 1981 423 435
40. M. Ristow M. Moehling M. Rifai New isoniazid/ethionamide resistance gene mutation and screening for multi-drug resistant Mycobacterium tuberculosis strains Lancet 346 1995 502 503
41. J.C. Sacchettini J.S. Blanchard The structure and function of the isoniazid target in M. tuberculosis Res Microbiol 147 1996 36 43
42. M. Salfinger G.E. Pfyffer The new diagnostic mycobacteriology laboratory Eur J Clin Microbiol Infect Dis 13 1994 961 979
43. A. Scorpio Y. Zhang Mutations in pcnA , a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus Nature Med 2 1996 662 667
44. D.R. Sherman P.J. Sabo M.J. Hickey Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria Proc Natl Acad Sci USA 92 1995 6625 6629
45. E.A. Sullivan B.N. Kreiswirth L. Palumbo Emergence of fluoroquinolone-resistant tuberculosis in New York city Lancet 345 1995 1148 1150
46. K. Takayama J.O. Kilburn Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob Agents Chemother 33 1989 1493 1499
47. H.E. Takiff M. Cimino C.M. Musso Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proc Natl Acad Sci USA 96 1996 362 366
48. H.E. Takiff L. Salazar C. Guerrero Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations Antimicrob Agents Chemother 38 1994 773 780
49. A. Telenti D.H. Persing Novel strategies for the detection of drug resistance in Mycobacterium tuberculosis. Res Microbiol 147 1996 73 79
50. A. Telenti P. Imboden F. Marchesi Detection of rifampicin-resistant mutations in Mycobacterium tuberculosis. Lancet 341 1993 647 650
51. A. Telenti P. Imboden F. Marchesi Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism Antimicrob Agents Chemother 37 1993 2054 2058
52. Telenti A. Philipp W. Sreevatsan S. Bernasconi C. Stockbauer K.E. Wieles B. Musser J.M. Jacobs W.R. Jr The emb operon: a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol Nature Med 1996 submitted
53. D.L. Williams C. Waguespack K. Eisenach Characterization of rifampin resistance in pathogenic mycobacteria Antimicrob Agents Chemother 38 1994 2380 2386
54. T.M. Wilson D.M. Collins ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex Mol Microbiol 19 1996 1025 1034
55. T.M. Wilson G.W. de Lisle D.M. Collins Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis. Mol Microbiol 15 1995 1009 1015
56. F.G. Winder Mode of action of the antimycobacterial agents and associated aspects of the molecular biology of the Mycobacteria C. Ratledge J. Stanford The Biology of the Mycobacteria. 1982 Academic Press New York 354 438
57. D.B. Young Strategies for new drug development B.R. Bloom Tuberculosis. Pathogenesis, Protection, and Control 1994 ASM Press Washington, DC 559 567
58. Y. Zhang B. Heym B. Allen The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358 1992 501 593